Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: Results of a Markov model for UK costs using data registries
References (44)
- et al.
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
Clin Ther
(2004) - et al.
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
J Am Coll Cardiol
(2002) - et al.
Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, doubleblind, placebo-controlled trial
Mayo Clin Proc
(2004) - et al.
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3)
J Am Coll Cardiol
(2005) The World Health Report 2002—Reducing Risks, Promoting Healthy Life
(2002)Reducing your blood cholesterol
- et al.
CHD: Estimating the Impact of Changes in Risk Factors
(2002) - et al.
Levels of dyslipidaemia and improvement in its management in England: Results from the Health Survey for England 2003
Clin Endocrinol (Oxf)
(2006) - et al.
A systematic review and economic evaluation of statins for the prevention of coronary events
Health Technol Assess
(2007)
Health Care Statistics
Health care statistics. Prescription cost analysis, 2005
Prescriptions dispensed in the community in Wales, 2000 to 2005 and prescription cost analysis (PCA) data
Ezetimibe for the treatment of hypercholesterolaemia: A systematic review and economic evaluation
Health Technol Assess
(2008)
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
Lancet
(2005)
Unit costs of health and social care 2006
Markov models in medical decision making: A practical guide
Med Decis Making
(1993)
Guide to the methods of Technology Appraisal (reference NO515)
British Heart Foundation statistics database. BHF 2004
Twenty years' experience of myocardial infarction: The value of a heart attack register
Br J Clin Pract
(1993)
Incidence and case fatality rates of stroke subtypes in a multiethnic population: The South London Stroke Register
J Neurol Neurosurg Psychiatry
(2002)
Efficacy and safety of coadministration of ezetimibe and simvastatin in African-American patients with primary hypercholesterolemia
J Natl Med Assoc
(2006)
Cited by (17)
Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial
2018, Heart Lung and CirculationCitation Excerpt :The results of the decision model should not be seen as contradictory to the findings of previous European studies that the combination of ezetimibe and statin is a cost-effective therapy compared with statin monotherapy. The review of those studies suggests that statin plus ezetimibe had better clinical outcomes with cost savings [46,47,48]. For example, Ara et al. reported that the ezetimibe and statin combination was cost-effective compared with statin monotherapy among the United Kingdom’s population [46].
Bridging science and health policy in cardiovascular disease: focus on lipid management. A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention - Health Policy, in Venice, Italy, on 25 October, 2008
2009, Atherosclerosis SupplementsThe cost-effectiveness and cost-utility of statin drug for the treatment of patients with cardiovascular disease, a systematic review
2021, International Journal of Preventive Medicine
Copyright © 2008 Published by Elsevier Inc.